(+)-pilocarpine multiple interactions EXP 6480464 Pilocarpine results in increased cleavage of and results in increased activity of CASP6 protein CTD PMID:12097334 (-)-anisomycin multiple interactions ISO RGD:732006 6480464 Anisomycin promotes the reaction [Indomethacin results in increased activity of CASP6 protein] CTD PMID:17341418 (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:732006 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of CASP6 mRNA CTD PMID:22079256 (R)-noradrenaline increases activity EXP 6480464 Norepinephrine results in increased activity of CASP6 protein CTD PMID:14732211 , PMID:15158148 (R)-noradrenaline multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [Norepinephrine results in increased activity of CASP6 protein], Ascorbic Acid inhibits the reaction [Norepinephrine results in increased activity of CASP6 protein] CTD PMID:15158148 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane decreases expression EXP 6480464 o, p'-DDT analog results in decreased expression of CASP6 mRNA CTD PMID:22937105 1,2-dimethylhydrazine multiple interactions ISO RGD:732007 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CASP6 mRNA CTD PMID:22206623 1,2-dimethylhydrazine decreases expression ISO RGD:732007 6480464 1, 2-Dimethylhydrazine results in decreased expression of CASP6 mRNA CTD PMID:22206623 1,3-dinitrobenzene increases expression EXP 6480464 3-dinitrobenzene results in increased expression of CASP6 mRNA CTD PMID:22841810 1,3-dinitrobenzene increases cleavage EXP 6480464 3-dinitrobenzene results in increased cleavage of CASP6 protein CTD PMID:22841810 17alpha-ethynylestradiol affects expression EXP 6480464 Ethinyl Estradiol affects the expression of CASP6 mRNA CTD PMID:15212814 17alpha-ethynylestradiol decreases expression ISO RGD:732007 6480464 Ethinyl Estradiol results in decreased expression of CASP6 mRNA CTD PMID:17942748 17alpha-ethynylestradiol affects expression ISO RGD:732007 6480464 Ethinyl Estradiol affects the expression of CASP6 mRNA CTD PMID:17555576 17alpha-ethynylestradiol multiple interactions ISO RGD:732007 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of CASP6 mRNA CTD PMID:17942748 17beta-estradiol affects expression ISO RGD:732006 6480464 Estradiol affects the expression of CASP6 mRNA CTD PMID:21826169 17beta-estradiol decreases expression ISO RGD:732007 6480464 Estradiol results in decreased expression of CASP6 mRNA CTD PMID:19693291 17beta-estradiol multiple interactions ISO RGD:732006 6480464 Estradiol results in increased degradation of and results in decreased activity of CASP6 protein, leupeptin inhibits the reaction [Estradiol results in increased degradation of and results in decreased activity of CASP6 protein] CTD PMID:15086513 17beta-estradiol decreases expression ISO RGD:732006 6480464 Estradiol results in decreased expression of CASP6 mRNA CTD PMID:23019147 , PMID:23373633 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO RGD:732006 6480464 2 more ... CTD PMID:27589474 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of CASP6 mRNA CTD PMID:16054898 , PMID:19520675 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:732007 6480464 Tetrachlorodibenzodioxin results in increased expression of CASP6 mRNA CTD PMID:15800033 , PMID:25975270 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:732007 6480464 Tetrachlorodibenzodioxin affects the expression of CASP6 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:732007 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of CASP6 mRNA, [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of CASP6 mRNA CTD PMID:17942748 , PMID:25975270 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of CASP6 mRNA CTD PMID:21346803 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of CASP6 mRNA CTD PMID:21346803 3,3',5,5'-tetrabromobisphenol A increases expression EXP 6480464 tetrabromobisphenol A results in increased expression of CASP6 mRNA CTD PMID:28970181 3-chloropropane-1,2-diol multiple interactions ISO RGD:732006 6480464 alpha-Chlorohydrin results in increased expression of and results in increased activity of CASP6 protein, quinoline-val-asp(OMe)-CH2-OPH inhibits the reaction [alpha-Chlorohydrin results in increased activity of CASP6 protein] CTD PMID:27732882 3-chloropropane-1,2-diol decreases expression ISO RGD:732006 6480464 alpha-Chlorohydrin results in decreased expression of CASP6 mRNA CTD PMID:27732882 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:732006 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CASP6 mRNA CTD PMID:28628672 3H-1,2-dithiole-3-thione decreases expression EXP 6480464 1, 2-dithiol-3-thione results in decreased expression of CASP6 mRNA CTD PMID:19162173 4-nonylphenol decreases expression EXP 6480464 4-nonylphenol results in decreased expression of CASP6 mRNA CTD PMID:27109770 5-aza-2'-deoxycytidine increases expression ISO RGD:732006 6480464 Decitabine results in increased expression of CASP6 mRNA CTD PMID:19037991 5-fluorouracil multiple interactions ISO RGD:732006 6480464 Fluorouracil results in increased cleavage of and results in increased activity of CASP6 protein more ... CTD PMID:18497562 5-fluorouracil affects expression ISO RGD:732006 6480464 Fluorouracil affects the expression of CASP6 mRNA CTD PMID:34151400 acetylsalicylic acid multiple interactions ISO RGD:732006 6480464 Aspirin inhibits the reaction [Deoxycholic Acid results in increased activity of CASP6 protein], Aspirin results in increased cleavage of and results in increased activity of CASP6 protein CTD PMID:15481331 , PMID:17644113 acrolein increases activity ISO RGD:732006 6480464 Acrolein results in increased activity of CASP6 protein CTD PMID:19596284 acrylamide increases expression ISO RGD:732006 6480464 Acrylamide results in increased expression of CASP6 mRNA CTD PMID:32763439 all-trans-retinoic acid decreases expression ISO RGD:732006 6480464 Tretinoin results in decreased expression of CASP6 mRNA CTD PMID:23724009 , PMID:33167477 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of CASP6 mRNA CTD PMID:16483693 ammonium chloride increases expression EXP 6480464 Ammonium Chloride results in increased expression of CASP6 protein CTD PMID:16483693 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions ISO RGD:732006 6480464 pyrazolanthrone inhibits the reaction [dehydroxymethylepoxyquinomicin results in increased cleavage of CASP6 protein] more ... CTD PMID:15501958 more ... anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions EXP 6480464 pyrazolanthrone inhibits the reaction [Vitamin K 3 results in increased activity of CASP6 protein], pyrazolanthrone inhibits the reaction [Vitamin K 3 results in increased cleavage of CASP6 protein] CTD PMID:16310883 arsane multiple interactions ISO RGD:732006 6480464 [Arsenic co-treated with Fluorides] results in decreased expression of CASP6 mRNA CTD PMID:19962721 arsane increases expression ISO RGD:732006 6480464 Arsenic results in increased expression of CASP6 mRNA CTD PMID:27838757 arsane decreases expression ISO RGD:732006 6480464 Arsenic results in decreased expression of CASP6 mRNA CTD PMID:11134558 arsenic atom multiple interactions ISO RGD:732006 6480464 [Arsenic co-treated with Fluorides] results in decreased expression of CASP6 mRNA CTD PMID:19962721 arsenic atom increases expression ISO RGD:732006 6480464 Arsenic results in increased expression of CASP6 mRNA CTD PMID:27838757 arsenic atom decreases expression ISO RGD:732006 6480464 Arsenic results in decreased expression of CASP6 mRNA CTD PMID:11134558 arsenous acid increases expression ISO RGD:732006 6480464 Arsenic Trioxide results in increased expression of CASP6 mRNA CTD PMID:11940349 arsenous acid multiple interactions ISO RGD:732007 6480464 Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased activity of CASP6 protein] CTD PMID:24157283 arsenous acid increases activity ISO RGD:732007 6480464 Arsenic Trioxide results in increased activity of CASP6 protein CTD PMID:24157283 azadirachtin A increases expression ISO RGD:732006 6480464 azadirachtin results in increased expression of CASP6 protein CTD PMID:20429769 benzo[a]pyrene increases expression ISO RGD:732006 6480464 Benzo(a)pyrene results in increased expression of CASP6 mRNA CTD PMID:21632981 benzo[a]pyrene affects methylation ISO RGD:732006 6480464 Benzo(a)pyrene affects the methylation of CASP6 promoter CTD PMID:27901495 benzo[a]pyrene increases activity EXP 6480464 Benzo(a)pyrene results in increased activity of CASP6 protein CTD PMID:22051199 benzo[a]pyrene multiple interactions EXP 6480464 Benzo(a)pyrene results in increased expression of and results in increased activity of CASP6 protein, Glycyrrhizic Acid inhibits the reaction [Benzo(a)pyrene results in increased activity of CASP6 protein] CTD PMID:22051199 , PMID:23510837 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:732006 6480464 7 more ... CTD PMID:20018196 bexarotene decreases expression EXP 6480464 bexarotene results in decreased expression of CASP6 mRNA CTD PMID:16648578 bis(2-chloroethyl) sulfide multiple interactions ISO RGD:732006 6480464 CALM1 protein promotes the reaction [Mustard Gas results in increased cleavage of and results in increased activity of CASP6 protein] more ... CTD PMID:12482751 more ... bis(2-chloroethyl) sulfide increases activity ISO RGD:732006 6480464 Mustard Gas results in increased activity of CASP6 protein CTD PMID:12482751 bisphenol A decreases expression ISO RGD:732006 6480464 bisphenol A results in decreased expression of CASP6 protein CTD PMID:21277958 bisphenol A increases expression ISO RGD:732007 6480464 bisphenol A results in increased expression of CASP6 mRNA CTD PMID:31453682 bisphenol A multiple interactions ISO RGD:732006 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CASP6 mRNA CTD PMID:28628672 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of CASP6 mRNA CTD PMID:30816183 , PMID:34947998 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of CASP6 mRNA CTD PMID:25181051 bisphenol F increases expression ISO RGD:732007 6480464 bisphenol F results in increased expression of CASP6 mRNA CTD PMID:31453682 bortezomib multiple interactions ISO RGD:732006 6480464 Bortezomib promotes the reaction [TNFSF10 protein results in increased cleavage of CASP6 protein], SCIO-469 promotes the reaction [Bortezomib results in increased cleavage of CASP6 protein] CTD PMID:16617327 , PMID:17510429 bortezomib increases cleavage ISO RGD:732006 6480464 Bortezomib results in increased cleavage of CASP6 protein CTD PMID:16617327 buspirone increases expression EXP 6480464 Buspirone results in increased expression of CASP6 mRNA CTD PMID:24136188 butyric acid increases expression EXP 6480464 Butyric Acid results in increased expression of CASP6 mRNA CTD PMID:12800193 cadmium atom increases expression ISO RGD:732006 6480464 Cadmium results in increased expression of CASP6 mRNA CTD PMID:24376830 calcitriol multiple interactions ISO RGD:732006 6480464 [Calcitriol co-treated with Gemcitabine] results in increased expression of CASP6 protein CTD PMID:20699664 cannabidiol decreases expression ISO RGD:732007 6480464 Cannabidiol results in decreased expression of CASP6 mRNA CTD PMID:33019509 cannabidiol multiple interactions ISO RGD:732006 6480464 [Cannabidiol co-treated with moringin] results in decreased expression of CASP6 mRNA CTD PMID:30096889 cannabidiol decreases expression ISO RGD:732006 6480464 Cannabidiol results in decreased expression of CASP6 mRNA CTD PMID:27932991 capsaicin multiple interactions ISO RGD:732006 6480464 [Capsaicin co-treated with TNFSF10 protein] results in increased cleavage of CASP6 protein CTD PMID:19939880 carbamazepine affects expression ISO RGD:732006 6480464 Carbamazepine affects the expression of CASP6 mRNA CTD PMID:24752500 carbon nanotube decreases expression ISO RGD:732007 6480464 Nanotubes more ... CTD PMID:25554681 casticin increases expression ISO RGD:732006 6480464 casticin results in increased expression of CASP6 protein CTD PMID:27862857 celecoxib multiple interactions ISO RGD:732006 6480464 Celecoxib results in increased cleavage of and results in increased activity of CASP6 protein, TNFSF10 protein promotes the reaction [Celecoxib results in increased cleavage of and results in increased activity of CASP6 protein] CTD PMID:15572759 chalcones multiple interactions ISO RGD:732006 6480464 BCL2 protein inhibits the reaction [Chalcones analog results in increased cleavage of CASP6 protein] CTD PMID:30576621 chalcones increases cleavage ISO RGD:732006 6480464 Chalcones analog results in increased cleavage of CASP6 protein CTD PMID:30576621 chelerythrine increases cleavage ISO RGD:732006 6480464 chelerythrine results in increased cleavage of CASP6 protein CTD PMID:26124276 cisplatin multiple interactions ISO RGD:732006 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of CASP6 mRNA CTD PMID:27392435 cisplatin multiple interactions ISO RGD:732007 6480464 PAK2 protein modified form promotes the reaction [Cisplatin results in increased activity of CASP6 protein] CTD PMID:21499899 cisplatin increases expression ISO RGD:732006 6480464 Cisplatin results in increased expression of CASP6 mRNA CTD PMID:27392435 cladribine multiple interactions ISO RGD:732006 6480464 Cladribine promotes the reaction [Bendamustine Hydrochloride results in increased activity of CASP6 protein] CTD PMID:12948851 cladribine increases activity ISO RGD:732006 6480464 Cladribine results in increased activity of CASP6 protein CTD PMID:11672427 , PMID:12948851 clobetasol increases expression ISO RGD:732007 6480464 Clobetasol results in increased expression of CASP6 mRNA CTD PMID:27462272 clofibrate decreases expression ISO RGD:732007 6480464 Clofibrate results in decreased expression of CASP6 mRNA CTD PMID:23811191 cobalt dichloride increases expression ISO RGD:732006 6480464 cobaltous chloride results in increased expression of CASP6 mRNA CTD PMID:19376846 copper atom multiple interactions ISO RGD:732006 6480464 [Thiosemicarbazones binds to Copper] which results in decreased expression of CASP6 protein CTD PMID:20931265 copper(0) multiple interactions ISO RGD:732006 6480464 [Thiosemicarbazones binds to Copper] which results in decreased expression of CASP6 protein CTD PMID:20931265 copper(II) sulfate decreases expression ISO RGD:732006 6480464 Copper Sulfate results in decreased expression of CASP6 mRNA CTD PMID:19549813 cyclosporin A decreases expression ISO RGD:732006 6480464 Cyclosporine results in decreased expression of CASP6 mRNA CTD PMID:20106945 more ... cypermethrin increases expression EXP 6480464 cypermethrin results in increased expression of CASP6 mRNA CTD PMID:22528246 deguelin multiple interactions ISO RGD:732006 6480464 [NPM1 protein mutant form results in increased susceptibility to deguelin] which results in decreased expression of and results in increased activity of CASP6 protein CTD PMID:25242579 deoxycholic acid affects response to substance ISO RGD:732006 6480464 CASP6 protein affects the susceptibility to Deoxycholic Acid CTD PMID:12507930 deoxycholic acid increases activity ISO RGD:732006 6480464 Deoxycholic Acid results in increased activity of CASP6 protein CTD PMID:17644113 deoxycholic acid multiple interactions ISO RGD:732006 6480464 Aspirin inhibits the reaction [Deoxycholic Acid results in increased activity of CASP6 protein] CTD PMID:17644113 dexamethasone multiple interactions ISO RGD:732006 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CASP6 mRNA CTD PMID:28628672 dexamethasone decreases expression ISO RGD:732007 6480464 Dexamethasone results in decreased expression of CASP6 mRNA CTD PMID:21041162 Di-n-octyl phthalate decreases expression ISO RGD:732007 6480464 di-n-octyl phthalate results in decreased expression of CASP6 protein CTD PMID:29128616 diarsenic trioxide increases expression ISO RGD:732006 6480464 Arsenic Trioxide results in increased expression of CASP6 mRNA CTD PMID:11940349 diarsenic trioxide increases activity ISO RGD:732007 6480464 Arsenic Trioxide results in increased activity of CASP6 protein CTD PMID:24157283 diarsenic trioxide multiple interactions ISO RGD:732007 6480464 Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased activity of CASP6 protein] CTD PMID:24157283 diazinon affects expression EXP 6480464 Diazinon affects the expression of CASP6 mRNA CTD PMID:22546817 dibutyl phthalate decreases expression ISO RGD:732007 6480464 Dibutyl Phthalate results in decreased expression of CASP6 mRNA CTD PMID:17361019 , PMID:21266533 diclofenac affects expression ISO RGD:732006 6480464 Diclofenac affects the expression of CASP6 mRNA CTD PMID:24752500 dicrotophos decreases expression ISO RGD:732006 6480464 dicrotophos results in decreased expression of CASP6 mRNA CTD PMID:28302478 dimethylarsinic acid affects binding ISO RGD:732006 6480464 CASP6 protein binds to Cacodylic Acid analog CTD PMID:21912678 doxorubicin affects activity ISO RGD:732006 6480464 Doxorubicin affects the activity of CASP6 protein CTD PMID:15870702 doxorubicin increases activity EXP 6480464 Doxorubicin results in increased activity of CASP6 protein CTD PMID:19801490 doxorubicin multiple interactions EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [NRG1 protein inhibits the reaction [Doxorubicin results in increased activity of CASP6 protein]], NRG1 protein inhibits the reaction [Doxorubicin results in increased activity of CASP6 protein] CTD PMID:19801490 doxorubicin multiple interactions ISO RGD:732006 6480464 TNFRSF10A protein affects the reaction [Doxorubicin results in increased activity of CASP6 protein] CTD PMID:17437844 doxorubicin increases expression ISO RGD:732006 6480464 Doxorubicin results in increased expression of CASP6 mRNA CTD PMID:16001973 doxorubicin increases activity ISO RGD:732006 6480464 Doxorubicin results in increased activity of CASP6 protein CTD PMID:17437844 , PMID:17922852 entinostat increases expression ISO RGD:732007 6480464 entinostat results in increased expression of CASP6 protein CTD PMID:29845424 epoxiconazole decreases expression ISO RGD:732007 6480464 epoxiconazole results in decreased expression of CASP6 mRNA CTD PMID:35436446 equol increases cleavage ISO RGD:732006 6480464 Equol results in increased cleavage of CASP6 protein CTD PMID:18973749 ethyl methanesulfonate increases expression ISO RGD:732006 6480464 Ethyl Methanesulfonate results in increased expression of CASP6 mRNA CTD PMID:23649840 flavonoids decreases expression EXP 6480464 Flavonoids results in decreased expression of CASP6 mRNA CTD PMID:18035473 flavonols multiple interactions ISO RGD:732006 6480464 Flavonols results in increased activity of and results in increased cleavage of CASP6 protein CTD PMID:28235426 fluoranthene multiple interactions ISO RGD:732007 6480464 [1-methylanthracene co-treated with fluoranthene] results in decreased expression of CASP6 mRNA CTD PMID:28329830 flutamide increases expression EXP 6480464 Flutamide results in increased expression of CASP6 mRNA CTD PMID:19299419 folic acid affects expression ISO RGD:732006 6480464 Folic Acid affects the expression of CASP6 mRNA CTD PMID:16361273 folic acid multiple interactions ISO RGD:732007 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CASP6 mRNA CTD PMID:22206623 formaldehyde increases expression ISO RGD:732006 6480464 Formaldehyde results in increased expression of CASP6 mRNA CTD PMID:23649840 furan increases methylation EXP 6480464 furan results in increased methylation of CASP6 gene CTD PMID:22079235 furosemide affects expression EXP 6480464 Furosemide affects the expression of CASP6 mRNA CTD PMID:17497460 gemcitabine multiple interactions ISO RGD:732006 6480464 [Calcitriol co-treated with Gemcitabine] results in increased expression of CASP6 protein CTD PMID:20699664 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of CASP6 mRNA CTD PMID:33387578 glutathione increases expression EXP 6480464 Glutathione deficiency results in increased expression of CASP6 mRNA CTD PMID:15345336 glycyrrhizinic acid multiple interactions EXP 6480464 Glycyrrhizic Acid inhibits the reaction [Benzo(a)pyrene results in increased activity of CASP6 protein] CTD PMID:22051199 glyphosate increases expression ISO RGD:732006 6480464 glyphosate results in increased expression of CASP6 mRNA CTD PMID:31874349 hydrogen peroxide affects expression ISO RGD:732006 6480464 Hydrogen Peroxide affects the expression of CASP6 mRNA, Hydrogen Peroxide affects the expression of CASP6 protein CTD PMID:20044591 , PMID:21179406 hydrogen peroxide multiple interactions ISO RGD:732007 6480464 PARP1 protein promotes the reaction [Hydrogen Peroxide results in increased cleavage of CASP6 protein] CTD PMID:20878536 hydrogen peroxide increases cleavage ISO RGD:732007 6480464 Hydrogen Peroxide results in increased cleavage of CASP6 protein CTD PMID:20878536 hydroquinone decreases expression ISO RGD:732006 6480464 hydroquinone results in decreased expression of CASP6 mRNA CTD PMID:15452088 indometacin multiple interactions ISO RGD:732006 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one affects the reaction [Indomethacin results in increased activity of CASP6 protein] more ... CTD PMID:17341418 , PMID:28628672 indometacin increases activity ISO RGD:732006 6480464 Indomethacin results in increased activity of CASP6 protein CTD PMID:17341418 isoprenaline decreases expression ISO RGD:732007 6480464 Isoproterenol results in decreased expression of CASP6 mRNA CTD PMID:21335049 ivermectin decreases expression ISO RGD:732006 6480464 Ivermectin results in decreased expression of CASP6 protein CTD PMID:32959892 ketamine increases activity ISO RGD:732006 6480464 Ketamine results in increased activity of CASP6 protein CTD PMID:19001360 ketoconazole decreases expression EXP 6480464 Ketoconazole results in decreased expression of CASP6 mRNA CTD PMID:25787151 ketoconazole increases expression EXP 6480464 Ketoconazole results in increased expression of CASP6 mRNA CTD PMID:25808816 L-ascorbic acid multiple interactions EXP 6480464 Ascorbic Acid inhibits the reaction [Norepinephrine results in increased activity of CASP6 protein] CTD PMID:15158148 leupeptin multiple interactions ISO RGD:732006 6480464 leupeptin inhibits the reaction [Estradiol results in increased degradation of and results in decreased activity of CASP6 protein] CTD PMID:15086513 lipopolysaccharide increases activity ISO RGD:732006 6480464 Lipopolysaccharides results in increased activity of CASP6 protein CTD PMID:20848084 lithium carbonate increases expression ISO RGD:732007 6480464 Lithium Carbonate results in increased expression of CASP6 protein CTD PMID:34984798 lovastatin increases activity ISO RGD:732006 6480464 Lovastatin results in increased activity of CASP6 protein CTD PMID:11720884 LY294002 multiple interactions ISO RGD:732006 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one affects the reaction [Indomethacin results in increased activity of CASP6 protein] CTD PMID:17341418 LY294002 multiple interactions EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [NRG1 protein inhibits the reaction [Doxorubicin results in increased activity of CASP6 protein]] CTD PMID:19801490 menadione multiple interactions EXP 6480464 pyrazolanthrone inhibits the reaction [Vitamin K 3 results in increased activity of CASP6 protein], pyrazolanthrone inhibits the reaction [Vitamin K 3 results in increased cleavage of CASP6 protein] CTD PMID:16310883 menadione increases cleavage EXP 6480464 Vitamin K 3 results in increased cleavage of CASP6 protein CTD PMID:16310883 methamphetamine increases cleavage EXP 6480464 Methamphetamine results in increased cleavage of CASP6 protein CTD PMID:32676729 methotrexate multiple interactions ISO RGD:732006 6480464 [Methotrexate co-treated with CDKN1A protein] results in decreased expression of CASP6 mRNA CTD PMID:18483502 methotrexate decreases expression ISO RGD:732006 6480464 Methotrexate results in decreased expression of CASP6 mRNA CTD PMID:18483502 methyl beta-cyclodextrin multiple interactions ISO RGD:732006 6480464 methyl-beta-cyclodextrin inhibits the reaction [Ursodeoxycholic Acid results in increased cleavage of CASP6 protein] CTD PMID:21362627 miconazole decreases expression EXP 6480464 Miconazole results in decreased expression of CASP6 mRNA CTD PMID:22262564 mitoxantrone increases activity ISO RGD:732006 6480464 Mitoxantrone results in increased activity of CASP6 protein CTD PMID:12948851 monosodium L-glutamate multiple interactions ISO RGD:732007 6480464 [Sodium Glutamate co-treated with High Fructose Corn Syrup] results in increased expression of CASP6 mRNA CTD PMID:20111022 Myrtucommulone A decreases expression ISO RGD:732007 6480464 myrtucommulone A results in decreased expression of CASP6 mRNA CTD PMID:26032814 N-acetyl-L-cysteine multiple interactions ISO RGD:732006 6480464 Acetylcysteine inhibits the reaction [surfactin peptide results in increased cleavage of and results in increased activity of CASP6 protein] CTD PMID:19954742 N-acetyl-L-cysteine multiple interactions ISO RGD:732007 6480464 Acetylcysteine inhibits the reaction [arsenic trioxide results in increased activity of CASP6 protein] CTD PMID:24157283 N-acetyl-L-cysteine multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [Norepinephrine results in increased activity of CASP6 protein] CTD PMID:15158148 N-acylsphinganine increases cleavage ISO RGD:732006 6480464 dihydroceramide metabolite results in increased cleavage of CASP6 protein CTD PMID:17586710 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions ISO RGD:732007 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [IFNG protein results in increased activity of CASP6 protein], Quercetin inhibits the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [IFNG protein results in increased activity of CASP6 protein]] CTD PMID:15914627 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal decreases activity ISO RGD:732007 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased activity of CASP6 protein CTD PMID:15914627 N-methyl-N-nitrosourea increases expression EXP 6480464 Methylnitrosourea results in increased expression of CASP6 mRNA CTD PMID:28688903 N-nitrosomorpholine increases expression EXP 6480464 N-nitrosomorpholine results in increased expression of CASP6 mRNA CTD PMID:19716841 nickel dichloride affects expression EXP 6480464 nickel chloride affects the expression of CASP6 mRNA CTD PMID:22546817 nitrates increases expression EXP 6480464 Nitrates results in increased expression of CASP6 mRNA CTD PMID:30022042 p-menthan-3-ol decreases expression ISO RGD:732006 6480464 Menthol results in decreased expression of CASP6 mRNA CTD PMID:26760959 Panduratin A increases cleavage ISO RGD:732006 6480464 panduratin A results in increased cleavage of CASP6 protein CTD PMID:16497706 paracetamol decreases expression ISO RGD:732006 6480464 Acetaminophen results in decreased expression of CASP6 mRNA CTD PMID:21420995 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of CASP6 mRNA CTD PMID:33387578 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:732007 6480464 perfluorooctane sulfonic acid results in decreased expression of CASP6 protein CTD PMID:26178269 perfluorooctanoic acid decreases expression EXP 6480464 perfluorooctanoic acid results in decreased expression of CASP6 protein CTD PMID:34958885 phenanthrolines multiple interactions EXP 6480464 Phenanthrolines inhibits the reaction [resveratrol results in increased cleavage of and results in increased activity of CASP6 protein] CTD PMID:18951995 pirinixic acid multiple interactions ISO RGD:732006 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of CASP6 mRNA CTD PMID:19710929 potassium chromate multiple interactions ISO RGD:732006 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of CASP6 mRNA CTD PMID:22079256 potassium chromate decreases expression ISO RGD:732006 6480464 potassium chromate(VI) results in decreased expression of CASP6 mRNA CTD PMID:22079256 pregnenolone 16alpha-carbonitrile decreases expression EXP 6480464 Pregnenolone Carbonitrile results in decreased expression of CASP6 mRNA CTD PMID:19162173 propiconazole decreases expression ISO RGD:732007 6480464 propiconazole results in decreased expression of CASP6 mRNA CTD PMID:21278054 propylparaben increases expression ISO RGD:732006 6480464 propylparaben results in increased expression of CASP6 mRNA CTD PMID:24481588 quercetin increases activity ISO RGD:732006 6480464 Quercetin results in increased activity of CASP6 protein CTD PMID:20803121 quercetin multiple interactions ISO RGD:732007 6480464 Quercetin inhibits the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [IFNG protein results in increased activity of CASP6 protein]] CTD PMID:15914627 quercetin increases expression ISO RGD:732006 6480464 Quercetin results in increased expression of CASP6 protein CTD PMID:30152185 quercetin decreases expression ISO RGD:732006 6480464 Quercetin results in decreased expression of CASP6 mRNA CTD PMID:21632981 resveratrol increases activity ISO RGD:732006 6480464 resveratrol results in increased activity of CASP6 protein CTD PMID:18497562 resveratrol decreases activity ISO RGD:732007 6480464 resveratrol results in decreased activity of CASP6 protein CTD PMID:20940732 resveratrol multiple interactions ISO RGD:732007 6480464 benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone promotes the reaction [resveratrol results in decreased activity of CASP6 protein] more ... CTD PMID:18951995 , PMID:20940732 resveratrol multiple interactions EXP 6480464 CASP6 protein affects the reaction [resveratrol results in decreased expression of SLC9A1 protein] more ... CTD PMID:18951995 resveratrol multiple interactions ISO RGD:732006 6480464 [Plant Extracts co-treated with Resveratrol] results in increased expression of CASP6 mRNA more ... CTD PMID:15763656 more ... rotenone increases expression EXP 6480464 Rotenone results in increased expression of CASP6 mRNA CTD PMID:28374803 rottlerin multiple interactions ISO RGD:732006 6480464 rottlerin inhibits the reaction [Ursodeoxycholic Acid results in increased cleavage of CASP6 protein] CTD PMID:21362627 SB 203580 multiple interactions ISO RGD:732006 6480464 SB 203580 inhibits the reaction [Indomethacin results in increased activity of CASP6 protein] CTD PMID:17341418 Se-methyl-L-selenocysteine increases expression ISO RGD:732006 6480464 selenomethylselenocysteine metabolite results in increased expression of CASP6 protein modified form CTD PMID:25321483 Se-methyl-L-selenocysteine multiple interactions ISO RGD:732006 6480464 BMF protein promotes the reaction [selenomethylselenocysteine metabolite results in increased expression of CASP6 protein modified form] CTD PMID:25321483 Se-methylselenocysteine increases expression ISO RGD:732006 6480464 selenomethylselenocysteine metabolite results in increased expression of CASP6 protein modified form CTD PMID:25321483 Se-methylselenocysteine multiple interactions ISO RGD:732006 6480464 BMF protein promotes the reaction [selenomethylselenocysteine metabolite results in increased expression of CASP6 protein modified form] CTD PMID:25321483 simvastatin multiple interactions ISO RGD:732006 6480464 Simvastatin results in increased cleavage of and results in increased activity of CASP6 protein CTD PMID:19253821 sodium arsenite decreases expression ISO RGD:732007 6480464 sodium arsenite results in decreased expression of CASP6 mRNA CTD PMID:16014739 sodium dichromate affects expression EXP 6480464 sodium bichromate affects the expression of CASP6 mRNA CTD PMID:11960910 staurosporine increases cleavage ISO RGD:732006 6480464 Staurosporine results in increased cleavage of CASP6 protein CTD PMID:26124276 streptozocin increases expression EXP 6480464 Streptozocin results in increased expression of CASP6 protein CTD PMID:15976052 sunitinib decreases expression ISO RGD:732006 6480464 Sunitinib results in decreased expression of CASP6 mRNA CTD PMID:31533062 surfactin affects response to substance ISO RGD:732006 6480464 CASP6 protein affects the susceptibility to surfactin peptide CTD PMID:19954742 surfactin multiple interactions ISO RGD:732006 6480464 Acetylcysteine inhibits the reaction [surfactin peptide results in increased cleavage of and results in increased activity of CASP6 protein] more ... CTD PMID:19954742 surfactin C affects response to substance ISO RGD:732006 6480464 CASP6 protein affects the susceptibility to surfactin peptide CTD PMID:19954742 surfactin C multiple interactions ISO RGD:732006 6480464 Acetylcysteine inhibits the reaction [surfactin peptide results in increased cleavage of and results in increased activity of CASP6 protein] more ... CTD PMID:19954742 tamoxifen affects expression ISO RGD:732007 6480464 Tamoxifen affects the expression of CASP6 mRNA CTD PMID:17555576 tauroursodeoxycholic acid multiple interactions ISO RGD:732006 6480464 ursodoxicoltaurine inhibits the reaction [[APP gene mutant form co-treated with PSEN1 gene mutant form] results in increased activity of CASP6 protein], ursodoxicoltaurine inhibits the reaction [APP gene mutant form results in increased activity of CASP6 protein] CTD PMID:16923170 Terfenadine increases activity ISO RGD:732006 6480464 Terfenadine results in increased activity of CASP6 protein CTD PMID:16569656 tert-butyl hydroperoxide increases expression ISO RGD:732007 6480464 tert-Butylhydroperoxide results in increased expression of CASP6 mRNA CTD PMID:15003993 testosterone multiple interactions EXP 6480464 Testosterone results in decreased cleavage of and results in decreased activity of CASP6 protein CTD PMID:12724284 testosterone decreases expression ISO RGD:732007 6480464 Testosterone results in decreased expression of CASP6 mRNA CTD PMID:19693291 testosterone decreases expression EXP 6480464 Testosterone results in decreased expression of CASP6 mRNA, Testosterone results in decreased expression of CASP6 protein CTD PMID:12724284 testosterone enanthate affects expression ISO RGD:732006 6480464 testosterone enanthate affects the expression of CASP6 mRNA CTD PMID:17440010 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of CASP6 mRNA CTD PMID:31150632 tetrachloromethane decreases expression ISO RGD:732007 6480464 Carbon Tetrachloride results in decreased expression of CASP6 mRNA CTD PMID:31919559 thapsigargin decreases expression ISO RGD:732007 6480464 Thapsigargin results in decreased expression of CASP6 protein CTD PMID:24648495 topotecan affects response to substance ISO RGD:732006 6480464 CASP6 protein affects the susceptibility to Topotecan CTD PMID:16217747 tributylstannane multiple interactions ISO RGD:732006 6480464 DFFB protein promotes the reaction [tributyltin results in decreased expression of CASP6 protein] CTD PMID:31401084 tributylstannane decreases expression ISO RGD:732006 6480464 tributyltin results in decreased expression of CASP6 protein CTD PMID:31401084 trovafloxacin increases expression EXP 6480464 trovafloxacin results in increased expression of CASP6 mRNA CTD PMID:24136188 tunicamycin decreases expression ISO RGD:732007 6480464 Tunicamycin results in decreased expression of CASP6 mRNA CTD PMID:17127020 ursodeoxycholic acid multiple interactions ISO RGD:732006 6480464 benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [Ursodeoxycholic Acid results in increased cleavage of and results in increased activity of CASP6 protein] more ... CTD PMID:21362627 valproic acid decreases expression ISO RGD:732006 6480464 Valproic Acid results in decreased expression of CASP6 mRNA CTD PMID:29154799 valproic acid increases expression ISO RGD:732006 6480464 Valproic Acid results in increased expression of CASP6 mRNA CTD PMID:24935251 vincristine increases expression ISO RGD:732006 6480464 Vincristine results in increased expression of CASP6 mRNA CTD PMID:16001973 zoledronic acid increases activity ISO RGD:732006 6480464 zoledronic acid results in increased activity of CASP6 protein CTD PMID:17070308